An Open-label, Phase II Study of AZD4635 in Patients with Prostate Cancer

Trial Identifier: D8731C00001
Sponsor: AstraZeneca
NCTID:: NCT04089553
Start Date: August 2019
Primary Completion Date: June 2021
Study Completion Date: April 2023
Condition: Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version

Trial Locations

Country Location
US, CA West Hollywood, CA, US, 90048
US, CO Denver, CO, US, 80218
US, CT New Haven, CT, US, 06510
US, FL Fort Myers, FL, US, 33916
US, FL St. Petersburg, FL, US, 33705
US, FL West Palm Beach, FL, US, 33401
US, IL Decatur, IL, US, 62526
US, MI Detroit, MI, US, 48201
US, NC Durham, NC, US, 27710
US, NE Omaha, NE, US, 68130
US, NY New York, NY, US, 10032
US, TN Chattanooga, TN, US, 37404
US, TN Nashville, TN, US, 37203